Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.
Identifieur interne : 001077 ( PubMed/Curation ); précédent : 001076; suivant : 001078Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.
Auteurs : E. Cuquemelle [France] ; F. Soulis ; D. Villers ; F. Roche-Campo ; C. Ara Somohano ; M. Fartoukh ; A. Kouatchet ; B. Mourvillier ; J. Dellamonica ; W. Picard ; M. Schmidt ; T. Boulain ; C. Brun-BuissonSource :
- Intensive care medicine [ 1432-1238 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Calcitonine (sang), Femelle, France, Grippe humaine (diagnostic), Grippe humaine (physiopathologie), Grippe humaine (virologie), Humains, Indice de gravité médicale, Infections bactériennes (diagnostic), Infections bactériennes (physiopathologie), Infections bactériennes (sang), Marqueurs biologiques, Mâle, Neuropeptide CGRP, Pneumopathie infectieuse (diagnostic), Pneumopathie infectieuse (physiopathologie), Pneumopathie infectieuse (virologie), Précurseurs de protéines (sang), Sensibilité et spécificité, Sous-type H1N1 du virus de la grippe A, Études rétrospectives.
- MESH :
- diagnostic : Grippe humaine, Infections bactériennes, Pneumopathie infectieuse.
- physiopathologie : Grippe humaine, Infections bactériennes, Pneumopathie infectieuse.
- sang : Calcitonine, Infections bactériennes, Précurseurs de protéines.
- virologie : Grippe humaine, Pneumopathie infectieuse.
- Adulte, Adulte d'âge moyen, Femelle, France, Humains, Indice de gravité médicale, Marqueurs biologiques, Mâle, Neuropeptide CGRP, Sensibilité et spécificité, Sous-type H1N1 du virus de la grippe A, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Bacterial Infections (blood), Bacterial Infections (diagnosis), Bacterial Infections (physiopathology), Biomarkers, Calcitonin (blood), Calcitonin Gene-Related Peptide, Female, France, Humans, Influenza A Virus, H1N1 Subtype, Influenza, Human (diagnosis), Influenza, Human (physiopathology), Influenza, Human (virology), Male, Middle Aged, Pneumonia (diagnosis), Pneumonia (physiopathology), Pneumonia (virology), Protein Precursors (blood), Retrospective Studies, Sensitivity and Specificity, Severity of Illness Index.
- MESH :
- chemical , blood : Calcitonin, Protein Precursors.
- chemical : Biomarkers, Calcitonin Gene-Related Peptide.
- blood : Bacterial Infections.
- diagnosis : Bacterial Infections, Influenza, Human, Pneumonia.
- physiopathology : Bacterial Infections, Influenza, Human, Pneumonia.
- virology : Influenza, Human, Pneumonia.
- Adult, Female, France, Humans, Influenza A Virus, H1N1 Subtype, Male, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Severity of Illness Index.
Abstract
To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic.
DOI: 10.1007/s00134-011-2189-1
PubMed: 21369807
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001077
Links to Exploration step
pubmed:21369807Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.</title><author><name sortKey="Cuquemelle, E" sort="Cuquemelle, E" uniqKey="Cuquemelle E" first="E" last="Cuquemelle">E. Cuquemelle</name><affiliation wicri:level="1"><nlm:affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, Université Paris-Est Créteil, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Réanimation médicale, Medical Intensive Care Unit, Université Paris-Est Créteil, Créteil</wicri:regionArea></affiliation></author><author><name sortKey="Soulis, F" sort="Soulis, F" uniqKey="Soulis F" first="F" last="Soulis">F. Soulis</name></author><author><name sortKey="Villers, D" sort="Villers, D" uniqKey="Villers D" first="D" last="Villers">D. Villers</name></author><author><name sortKey="Roche Campo, F" sort="Roche Campo, F" uniqKey="Roche Campo F" first="F" last="Roche-Campo">F. Roche-Campo</name></author><author><name sortKey="Ara Somohano, C" sort="Ara Somohano, C" uniqKey="Ara Somohano C" first="C" last="Ara Somohano">C. Ara Somohano</name></author><author><name sortKey="Fartoukh, M" sort="Fartoukh, M" uniqKey="Fartoukh M" first="M" last="Fartoukh">M. Fartoukh</name></author><author><name sortKey="Kouatchet, A" sort="Kouatchet, A" uniqKey="Kouatchet A" first="A" last="Kouatchet">A. Kouatchet</name></author><author><name sortKey="Mourvillier, B" sort="Mourvillier, B" uniqKey="Mourvillier B" first="B" last="Mourvillier">B. Mourvillier</name></author><author><name sortKey="Dellamonica, J" sort="Dellamonica, J" uniqKey="Dellamonica J" first="J" last="Dellamonica">J. Dellamonica</name></author><author><name sortKey="Picard, W" sort="Picard, W" uniqKey="Picard W" first="W" last="Picard">W. Picard</name></author><author><name sortKey="Schmidt, M" sort="Schmidt, M" uniqKey="Schmidt M" first="M" last="Schmidt">M. Schmidt</name></author><author><name sortKey="Boulain, T" sort="Boulain, T" uniqKey="Boulain T" first="T" last="Boulain">T. Boulain</name></author><author><name sortKey="Brun Buisson, C" sort="Brun Buisson, C" uniqKey="Brun Buisson C" first="C" last="Brun-Buisson">C. Brun-Buisson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21369807</idno><idno type="pmid">21369807</idno><idno type="doi">10.1007/s00134-011-2189-1</idno><idno type="wicri:Area/PubMed/Corpus">001077</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001077</idno><idno type="wicri:Area/PubMed/Curation">001077</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001077</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.</title><author><name sortKey="Cuquemelle, E" sort="Cuquemelle, E" uniqKey="Cuquemelle E" first="E" last="Cuquemelle">E. Cuquemelle</name><affiliation wicri:level="1"><nlm:affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, Université Paris-Est Créteil, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Réanimation médicale, Medical Intensive Care Unit, Université Paris-Est Créteil, Créteil</wicri:regionArea></affiliation></author><author><name sortKey="Soulis, F" sort="Soulis, F" uniqKey="Soulis F" first="F" last="Soulis">F. Soulis</name></author><author><name sortKey="Villers, D" sort="Villers, D" uniqKey="Villers D" first="D" last="Villers">D. Villers</name></author><author><name sortKey="Roche Campo, F" sort="Roche Campo, F" uniqKey="Roche Campo F" first="F" last="Roche-Campo">F. Roche-Campo</name></author><author><name sortKey="Ara Somohano, C" sort="Ara Somohano, C" uniqKey="Ara Somohano C" first="C" last="Ara Somohano">C. Ara Somohano</name></author><author><name sortKey="Fartoukh, M" sort="Fartoukh, M" uniqKey="Fartoukh M" first="M" last="Fartoukh">M. Fartoukh</name></author><author><name sortKey="Kouatchet, A" sort="Kouatchet, A" uniqKey="Kouatchet A" first="A" last="Kouatchet">A. Kouatchet</name></author><author><name sortKey="Mourvillier, B" sort="Mourvillier, B" uniqKey="Mourvillier B" first="B" last="Mourvillier">B. Mourvillier</name></author><author><name sortKey="Dellamonica, J" sort="Dellamonica, J" uniqKey="Dellamonica J" first="J" last="Dellamonica">J. Dellamonica</name></author><author><name sortKey="Picard, W" sort="Picard, W" uniqKey="Picard W" first="W" last="Picard">W. Picard</name></author><author><name sortKey="Schmidt, M" sort="Schmidt, M" uniqKey="Schmidt M" first="M" last="Schmidt">M. Schmidt</name></author><author><name sortKey="Boulain, T" sort="Boulain, T" uniqKey="Boulain T" first="T" last="Boulain">T. Boulain</name></author><author><name sortKey="Brun Buisson, C" sort="Brun Buisson, C" uniqKey="Brun Buisson C" first="C" last="Brun-Buisson">C. Brun-Buisson</name></author></analytic><series><title level="j">Intensive care medicine</title><idno type="eISSN">1432-1238</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Bacterial Infections (blood)</term><term>Bacterial Infections (diagnosis)</term><term>Bacterial Infections (physiopathology)</term><term>Biomarkers</term><term>Calcitonin (blood)</term><term>Calcitonin Gene-Related Peptide</term><term>Female</term><term>France</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human (diagnosis)</term><term>Influenza, Human (physiopathology)</term><term>Influenza, Human (virology)</term><term>Male</term><term>Middle Aged</term><term>Pneumonia (diagnosis)</term><term>Pneumonia (physiopathology)</term><term>Pneumonia (virology)</term><term>Protein Precursors (blood)</term><term>Retrospective Studies</term><term>Sensitivity and Specificity</term><term>Severity of Illness Index</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Calcitonine (sang)</term><term>Femelle</term><term>France</term><term>Grippe humaine (diagnostic)</term><term>Grippe humaine (physiopathologie)</term><term>Grippe humaine (virologie)</term><term>Humains</term><term>Indice de gravité médicale</term><term>Infections bactériennes (diagnostic)</term><term>Infections bactériennes (physiopathologie)</term><term>Infections bactériennes (sang)</term><term>Marqueurs biologiques</term><term>Mâle</term><term>Neuropeptide CGRP</term><term>Pneumopathie infectieuse (diagnostic)</term><term>Pneumopathie infectieuse (physiopathologie)</term><term>Pneumopathie infectieuse (virologie)</term><term>Précurseurs de protéines (sang)</term><term>Sensibilité et spécificité</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Calcitonin</term><term>Protein Precursors</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Biomarkers</term><term>Calcitonin Gene-Related Peptide</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Bacterial Infections</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Bacterial Infections</term><term>Influenza, Human</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term><term>Infections bactériennes</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Grippe humaine</term><term>Infections bactériennes</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Bacterial Infections</term><term>Influenza, Human</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Calcitonine</term><term>Infections bactériennes</term><term>Précurseurs de protéines</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term><term>Pneumonia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>France</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Sensitivity and Specificity</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>France</term><term>Humains</term><term>Indice de gravité médicale</term><term>Marqueurs biologiques</term><term>Mâle</term><term>Neuropeptide CGRP</term><term>Sensibilité et spécificité</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21369807</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.</ArticleTitle><Pagination><MedlinePgn>796-800</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-011-2189-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37-56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25-75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9-45.3) versus 0.5 (0.12-2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2-51.5; P < 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cuquemelle</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, Université Paris-Est Créteil, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soulis</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Villers</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Roche-Campo</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ara Somohano</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Fartoukh</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kouatchet</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mourvillier</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Dellamonica</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Picard</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boulain</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Brun-Buisson</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><CollectiveName>A/H1N1 REVA-SRLF Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606589">CALCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>JHB2QIZ69Z</RegistryNumber><NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Brochard</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brun-Buisson</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mercat</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richard</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouatchet</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arroudj</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Royer</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roche Campo</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mancebo</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charron</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vieillard-Baron</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ait Hssain</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuquemelle</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Somohano</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Timsit</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chanques</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jung</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vivier</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chelha</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villiers</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mourvillier</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yaba</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faisy</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhiel</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Megarbane</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmidt</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luyt</LastName><ForeName>C E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Combes</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fartoukh</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Djibre</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soulis</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richard</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Theodore</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Combes</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boulain</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capron</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Picard</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badia</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beuret</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dellamonica</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ricome</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robin</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21369807</ArticleId><ArticleId IdType="doi">10.1007/s00134-011-2189-1</ArticleId><ArticleId IdType="pmc">PMC7080069</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crit Care Med. 2006 Oct;34(10 ):2596-602</Citation><ArticleIdList><ArticleId IdType="pubmed">16915118</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2004 May;48(4):303-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15066330</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1935-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19815859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2000 Jul;19(7):598-602</Citation><ArticleIdList><ArticleId IdType="pubmed">10917215</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Rev. 2006 Jul;19(3):571-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16847087</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Jan 15;50(2):175-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20014948</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1997 Jun;24(6):1240-2</Citation><ArticleIdList><ArticleId IdType="pubmed">9195090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Feb 6;375(9713):463-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20097417</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Dec 31;4(12):e8540</Citation><ArticleIdList><ArticleId IdType="pubmed">20046873</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):55-60</Citation><ArticleIdList><ArticleId IdType="pubmed">18677519</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2004 Jul 15;39(2):206-17</Citation><ArticleIdList><ArticleId IdType="pubmed">15307030</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2010 Nov;31(11):1177-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20923284</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Sep 9;302(10 ):1059-66</Citation><ArticleIdList><ArticleId IdType="pubmed">19738090</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2010 Mar;36(3):528-32</Citation><ArticleIdList><ArticleId IdType="pubmed">20069274</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2007 Sep;30(3):556-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17766633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001077 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001077 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21369807
|texte= Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21369807" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |